[PCRX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
03-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -103.49%
YoY- -103.92%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 169,467 160,341 171,955 167,466 169,411 157,991 159,194 4.26%
PBT 37,854 -26,474 -18,068 2,069 22,007 7,294 -6,197 -
Tax 12,091 -6,938 -7,966 2,762 2,131 466 -1,068 -
NP 25,763 -19,536 -10,102 -693 19,876 6,828 -5,129 -
Tax Rate -31.94% - - -133.49% -9.68% -6.39% - -
Total Cost 143,704 179,877 182,057 168,159 149,535 151,163 164,323 -8.57%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 15.20 -12.18 -5.87 -0.41 11.73 4.32 -3.22 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS 0.56 -0.43 -0.22 -0.02 0.40 0.15 -0.12 -
EPS Diluted 0.49 -0.43 -0.22 -0.02 0.38 0.15 -0.12 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.